Yesil Science / Blog
Blog
Every article we have published: research summaries, product thinking and developments in health AI.
Latest articles

AI agents beat static databases in kidney care
Adding medical guidelines to an AI does not make it a better doctor, but teaching it to argue with itself does.

Retinal Implants Move From Lab to Market
A new commercial retinal implant challenges the boundary between biological sight and digital translation, forcing healthcare to rethink how we treat blindness.

AI co-learning cuts medical record labeling costs
A new human-AI framework shows that the best way to clean up messy electronic health records is to let algorithms and doctors...

The Validation Crisis
As clinical AI transitions to active decision-making, a wave of validation failures and self-overestimation is forcing healthcare buyers to inherit the entire...

NHS Bets Big On AI Voice Tech
NHS England is deploying ambient voice technology to 70,000 clinicians in its largest regional rollout yet, testing whether AI can finally solve...

AI ECG detects hidden structural heart disease
A new composite AI model can spot structural heart disease from a standard ECG before symptoms even appear, but its real value...

AI groups blood pressure data to predict risk
A new machine learning model proves that how your blood pressure fluctuates over 24 hours is far more dangerous than a single...

When Telehealth Scale Collides With Patient Safety
The rush to digitize GLP-1 prescribing is exposing a dangerous rift between venture-backed growth targets and basic clinical caution.

Feeding raw data to medical AI backfires
A new benchmark reveals that how we format electronic health records for large language models completely alters their clinical accuracy.

The Ophthalmology AI Report — July 2026
AI-Based Classification of Multiple Sclerosis Using OCT Retinal Layer Thickness Across Two Centers

Tempus AI Buys Personalis for $1.5 Billion
A massive consolidation in cancer diagnostics reveals the steep financial price of dominating the liquid biopsy market.

AI Models Miss Atypical Alzheimer’s Brain Scans
Deep learning models trained to spot Alzheimer's disease are systematically blind to atypical forms of brain decay, raising doubts about their readiness...
Also on LinkedIn
AI Health Hub posts the same research summaries on LinkedIn every day. More than 3,000 people follow it there.